Clinics in New Mexico

By the PeptideAgent Editorial Team. Draft, pending editorial review. Last verified Sep 22, 2026

What New Mexico law means for peptide clinics: who may prescribe, whether pharmacies may compound GLP-1 drugs (limited), how to check a clinic, and verified listings.

New Mexico at a glance

Pharmacy regulator: New Mexico Board of Pharmacy (Regulation and Licensing Department)
503A framework: Follows the federal 503A framework
Telehealth prescribing: Regulatory: Telehealth allowed
Asynchronous prescribing: Regulatory: Async unclear
Compounded GLP-1 access: Regulatory: Compounded GLP-1 limited

Verified clinics serving New Mexico

No verified clinics serving New Mexico are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Peptide access rules in New Mexico

Yes. A New Mexico resident can obtain FDA approved peptides such as semaglutide and tirzepatide from a New Mexico-licensed prescriber, including by telehealth, which the New Mexico Telehealth Act (NMSA 1978, sections 24-25-1 to 24-25-7) defines to include interactive audio and video and store-and-forward technology. A compounded peptide is available when it is eligible under federal 503A rules and dispensed by a pharmacy licensed by the New Mexico Board of Pharmacy; out-of-state pharmacies need a New Mexico nonresident pharmacy license, and nonresident pharmacies that ship sterile compounded preparations such as injectable peptides apply under a separate nonresident sterile application tied to the Board's sterile compounding rule, 16.19.36 NMAC. [1] [2] [3] [4] [5] [6] [7] [9]

Compounded GLP-1 access in New Mexico

Because compounded GLP-1 injections are sterile preparations, an out-of-state pharmacy shipping them into New Mexico must hold the Board's nonresident sterile licensure and meet 16.19.36 NMAC standards. [6] [7] [10]

Research use only sellers in New Mexico

The New Mexico Drug, Device and Cosmetic Act (NMSA 1978, sections 26-1-1 and following) prohibits selling adulterated or misbranded drugs and limits dispensing of dangerous drugs to licensed practitioners and pharmacies. [8] [11]

New Mexico notes on specific peptides

Tirzepatide: Available branded by prescription. Compounded tirzepatide is limited to the federal patient specific exception since February 18, 2025, and any compounded injection must be prepared under 16.19.36 NMAC or an equivalent nonresident sterile license. [6] [10]

How to check a clinic in New Mexico

Confirm the prescribing clinician's license with the New Mexico medical or nursing board.
Ask which pharmacy compounds or dispenses the peptide and check it in the New Mexico Board of Pharmacy (Regulation and Licensing Department) license lookup. [1] [2] [3] [6] [7] [9]
Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in New Mexico. [8] [11]

Common questions in New Mexico

Can I get a GLP-1 prescription in New Mexico through telehealth?

Yes, from a New Mexico-licensed prescriber. The New Mexico Telehealth Act recognizes audio, video, and store-and-forward telehealth, and semaglutide and tirzepatide are not controlled substances. The prescriber's licensing board sets the prescribing standard. [4] [5]

All peptide legal questions for New Mexico